Neovascularization derived from cell transplantation in ischemic myocardium

Molecular and Cellular Biochemistry

Volumn 264, Issue 1-2, 2004, Pages 133-142

  Angoulvant, Denis ^a   Fazel, Shafie ^a   Li, Ren Ke ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Angiogenesis; Cell therapy; Ischemic heart disease; Stem cells; Ventricular remodeling

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RECOMBINANT VASCULOTROPIN; SCATTER FACTOR;

ANGIOGENESIS; BONE MARROW TRANSPLANTATION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC DISEASE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MOLECULAR DYNAMICS; MYOBLAST; NONHUMAN; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; SURVIVAL; TUMOR; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL TRANSPLANTATION; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; GENE THERAPY; HUMANS; LASERS; MODELS, BIOLOGICAL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; VENTRICULAR REMODELING;

EID: 5544288560     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000044382.02403.9c     Document Type: Review

References (114)

1. Sutton GC: Epidemiologic aspects of heart failure. Am Heart J 120: 1538-1540, 1990
2. Berry C, Murdoch DR, McMurray JJ: Economics of chronic heart failure. Eur J Heart Fail 3: 283-291, 2001
3. Williams RS, Benjamin IJ: Protective response in the ischemic myocardium. J Clin Invest 106: 813-818, 2000
4. Schaper W, Ito WD: Molecular mechanisms of coronary collateral vessel growth. Circ Res 79: 911-919, 1996
5. Murohara T: Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 257-278, 1998
6. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, Anversa P: Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226: 316-327, 1996
7. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335: 1182-1189, 1996
8. Itescu S, Kocher AA, Schuster MD: Myocardial neovascularization by adult bone marrow-derived angioblasts: Strategies for improvement of cardiomyocyte function. Heart Fail Rev 8: 253-258, 2003
9. Braunwald E, Rutherford JD: Reversible ischemic left ventricular dysfunction: EIidence for the "hibernating myocardium". J Am Coll Cardiol 8: 1467-1470, 1986
10. Rahimtoola SH: From coronary artery diseaRe to heart failure: role of the hibernating myocardium. Am J Cardiol 75: 16E-22E, 1995
11. Elefteriades JA, Tolis G Jr., Levi E, Mills LK, Zaret BL: Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 22: 1411-1417, 1993
12. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R: Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344: 563-570, 1994
13. Al-Radi OO, Rao V, Li RK, Yau T, Weisel RD: Cardiac cell transplantation: Closer to bedside. Ann Thorac Surg 75: S674-S677, 2003
14. Reinecke H, Zhang M, Bartosek T, Murry CE: Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation 100: 193-202, 1999
15. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE: Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J Mol Cell Cardiol 33: 907-921, 2001
16. Couffinhal T, Dufourcq P, Daret D, Duplaa C: [The mechanisms of angiogenesis. Medical and therapeutic applications]. Rev Med Interne 22: 1064-1082, 2001
17. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997
18. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo J 18: 3964-3972, 1999
19. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000
20. Malekan R, Reynolds C, Narula N, Kelley ST, Suzuki Y, Bridges CR: Angiogenesis in transmyocardial laser revascularization. A nonspecific response to injury. Circulation 98: II62-II65; discussion II66, 1998
21. Chu V, Kuang J, McGinn A, Giaid A, Korkola S, Chiu RC: Angiogenic response induced by mechanical transmyocardial revascularization. J Thorac Cardiovasc Surg 118: 849-856, 1999
22. Li W, Tanaka K, Chiba Y, Kimura T, Morioka K, Uesaka T, Ihaya A, Sasaki M, Tsuda T, Yamada N: Role of MMPs and plasminogen activators in angiogenesis after transmyocardial laser revascularization in dogs. Am J Physiol Heart Circ Physiol 284: H23-H30, 2003
23. Landolfo CK, Landolfo KP, Hughes GC, Coleman ER, Coleman RB, Lowe JE: Intermediate-term clinical outcome following transmyocardial laser revascularization in patients with refractory angina pectoris. Circulation 100: II128-II133, 1999
24. Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T, Buxton M, Wallwork J: Transmyocardial laser revascularisation in patients with refractory angina: A randomised controlled trial. Lancet 353: 519-524, 1999
25. Rimoldi O, Burns SM, Rosen SD, Wistow TE, Schofield PM, Taylor G, Camici PG: Measurement of myocardial blood flow with positron emission tomography before and after transmyocardial laser revascularization. Circulation 100: II134-II138, 1999
26. Frazier OH, March RJ, Horvath KA: Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 341: 1021-1028, 1999
27. Kornowski R, Baim DS, Moses JW, Hong MK, Laham RJ, Fuchs S, Hendel RC, Wallace D, Cohen DJ, Bonow RO, Kuntz RE, Leon MB: Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping. Circulation 102: 1120-1125, 2000
28. Spertus JA, Jones PG, Coen M, Carg M, Bliven B, O'Keefe J, March RJ, Horvath KA: Transmyocardial CO(2) laser revascularization improves symptoms, function, and quality of life: 12-Month results from a randomized controlled trial. Am J Med 111: 341-348, 2001
29. Stone GW, Teirstein PS, Rubenstein R, Schmidt D, Whitlow PL, Kosinski EJ, Mishkel G, Power JA: A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol 39: 1581-1587, 2002
30. Guleserian KJ, Maniar HS, Camillo CJ, Bailey MS, Damiano RJJ, Moon MR: Quality of life and survival after transmyocardial laser revascularization with the holmium:YAG laser. Ann Thorac Surg 75: 1842-1848, 2003
31. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C: Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257: 1401-1403, 1992
32. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM: Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol 267: H1263-H1271, 1994
33. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF: Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89: 2183-2189, 1994
34. Sato K, Laham RJ, Pearlman JD, Novicki D, Sellke FW, Simons M, Post MJ: Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia. Ann Thorac Surg 70: 2113-2118, 2000
35. Sato K, Wu T, Laham RJ, Johnson RB, Douglas P, Li J, Sellke FW, Bunting S, Simons M, Post MJ: Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol 37: 616-623, 2001
36. Udelson JE, Dilsizian V, Laham RJ, Chronos N, Vansant J, Blais M, Galt JR, Pike M, Yoshizawa C, Simons M: Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation 102: 1605-1610, 2000
37. Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Losordo DW, Hendel RC, Bonow RO, Eppler SM, Zioncheck TF, Holmgren EB, McCluskey ER: Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J 142: 872-880, 2001
38. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER: The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107: 1359-1365, 2003
39. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF, Isner JM: Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94: 3281-3290, 1996
40. Funatsu T, Sawa Y, Ohtake S, Takahashi T, Matsumiya G, Matsuura N, Nakamura T, Matsuda H: Therapeutic angiogenesis in the ischemic canine heart induced by myocardial injection of naked complementary DNA plasmid encoding hepatocyte growth factor. J Thorac Cardiovasc Surg 124: 1099-1105, 2002
41. Zhang D, Gai L, Fan R, Dong W, Wen Y: Efficacy and safety of therapeutic angiogenesis from direct myocardial administration of an adenoviral vector expressing vascular endothelial growth factor 165. Chin Med J 115: 643-648, 2002
42. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DA, Li RK: Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104: I218-I222, 2001
43. Yamamoto M, Sakakibara Y, Nishimura K, Komeda M, Tabata Y: Improved therapeutic efficacy in cardiomyocyte transplantation for myocardial infarction with release system of basic fibroblast growth factor. Artif Organs 27: 181-184, 2003
44. Miyagawa S, Sawa Y, Taketani S, Kawaguchi N, Nakamura T, Matsuura N, Matsuda H: Myocardial regeneration therapy for heart failure: Hepatocyte growth factorenhances the effect of cellular cardiomyoplasty. Circulation 105: 2556-2561, 2002
45. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM: Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98: 2800-2804, 1998
46. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG: Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100: 468-474, 1999
47. Hedman M, Hartikainen J, Syvanne M, Stjernvall J, Hedman A, Kivela A, Vanninen E, Mussalo H, Kauppila E, Simula S, Narvaneeen O, Rantaala A, Peuhkurinen K, Niemineeen MS, Laaksso MY, La-Herttuala S: Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107: 2677-2683, 2002
48. Asahara T, Kalka C, Isner JM: Stem cell therapy and gene transfer for regeneration. Gene Ther 7: 451-457, 2000
49. Kalka C, Tehrani H, Laudenberg B, Vale PR, Isner JM, Asahara T, Symes JF: VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg 70: 829-834, 2000
50. Tang GH, Fedak PW, Yau TM, Weisel RD, Kulik A, Mickle DA, Li RK: Cell transplantation to improve ventricular function in the failing heart. Eur J Cardiothorac Surg 23: 907-916, 2003
51. Hassink RJ, Brutel de la Riviere A, Mummery CL, Doevendans PA: Transplantation of cells for cardiac repair. J Am Coll Cardiol 41: 711-717, 2003
52. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S: Endothelial progenitor cells: New hope for a broken heart. Circulation 107: 3093-3100, 2003
53. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G: A common precursor for hematopoietic and endothelial cells. Development 125: 725-732, 1998
54. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP: Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77, 2000
55. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T: Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105: 1527-1536, 2000
56. Eggermann J, Kliche S, Jarmy G, Hoffmann K, Mayr-Beyrle U, Debatin KM, Waltenberger J, Beltinger C: Endothelial progenitor cell culture and differentiation in vitro: A methodological comparison using human umbilical cord blood. Cardiovasc Res 58: 478-486, 2003
57. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK, Fiedler W: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112, 2000
58. Hristov M, Erl W, Weber PC: Endothelial progenitor cells: Isolation and characterization. Trends Cardiovasc Med 13: 201-206, 2003
59. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958, 2000
60. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T: Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732-738, 2002
61. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890, 2001
62. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, Mayer JE: Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7: 1035-1040, 2001
63. Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM, Dimmeler S: Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107: 1024-1032, 2003
64. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T: Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637, 2001
65. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436, 2001
66. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107: 461-468, 2003
67. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-3017, 2002
68. Li Z, Bonnet J: Mécanismes intrinsèques du controle de la différenciaton du muscle lisse vasculaire. In Biologic et pathologie du coeur et des vaisseaux., Flammarion, Paris, 2002, pp. 455-462
69. Koide M, Kawahaa Y, Nakayama I, Tsuda T, Yokoama M: Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory. J Biol Chem 268: 24959-24966, 1993
70. Ali S, Becker MW, Davis MG, Dorn WG: Dissociation o vasoconstrictor-simulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smoot muscle cells. Relevant roles of protein kinase C. Circ Res 75: 836-843, 1994
71. Stavri GT, Zachay IC, Baskerville PA, Martin JF, Erusalimsky JD: Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 92: 11-14, 1995
72. Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA: Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 31: 513-522, 1999
73. Chiu RC, Zibaitis A, Kao RL: Cellular cardiomyoplasty: Myocardial regeneration with satellite cell implantation. Ann Thorac Surg 60: 12-18, 1995
74. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD: Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98: 2512-2523, 1996
75. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE: Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933, 1998
76. Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, Menasche P: Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 119: 1169-1175, 2000
77. Pouzet B, Vilquin JT, Hagege AA, Scorsin M, Messas E, Fiszman M, Schwartz K, Menasche P: Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 71: 844-850; discussion 850-851, 2001
78. Menashe P, Hagege A, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D: Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1083, 2003
79. Menasche P: Skeletal muscle satellite cell transplantation. Cardiovasc Res 58: 351-357, 2003
80. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH: Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104: 1207-1212, 2001
81. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98: 10344-10349, 2001
82. Hirschi KK, Goodell MA: Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther 9: 648-652, 2002
83. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, Kornowski R: Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37: 1726-1732, 2001
84. Vicario J, Piva J, Pierini A, Ortega HH, Canal A, Gerardo L, Pfeiffer H, Campos C, Fendrich I, Novero R, Monti A: Transcoronary sinus delivery of autologous bone marrow and angiogenesis in pig models with myocardial injury. Cardiovasc Radiat Med 3: 91-94, 2002
85. Nishida M, Li TS, Hirata K, Yano M, Matsuzaki M, Hamano K: Improvement of cardiac function by bone marrow cell implantation in a rat hypoperfusion heart model. Ann Thorac Surg 75: 768-773; discussion 773-774, 2003
86. Kamihata H, Matsubara H, Nishiue T, Fujiyama, S, Tsutsumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E, Kosaki A, Shintani S, Murohara T, Imaizumi T, Iwasaka T: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052, 2001
87. Strauer BD, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, Kögler G, Wernet P: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918, 2002
88. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP: Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361: 47-49, 2003
89. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT: Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107: 2294-2302, 2003
90. Agbulut O, Menot ML, Li Z, Marotte F, Paulin D, Hagege AA, Chomienne C, Samuel JL, Menasche P: Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc Res 58: 451-459, 2003
91. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-377, 2001
92. Moore MAS, Hattori K, Heissig B, Shieh J-H, Dias S, Crystal RG, Rafii S: Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann NY Acad Sci 938: 2001, 36-47.
93. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705, 2001
94. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402, 2001
95. Caplan AI: Mesenchymal stem cells. J Orthop Res 9: 641-650, 1991
96. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74, 1997
97. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman RA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999
98. Conget PA, Minguell JJ: Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181: 67-73, 1999
99. Hughes S: Cardiac stem cells. J Pathol 197: 468-478, 2002
100. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, Jia ZQ: Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100: II247-II256, 1999
101. Wang JS, Shum-Tim D, Chedrawy E, Chiu RC: The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 122: 699-705, 2001
102. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, Allidina Y, Liu P, Li RK: Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123: 1132-1140, 2002
103. Minguell JJ, Erices A, Conget P: Mesenchymal stem cells. Exp Biol Med (Maywood) 226: 507-520, 2001
104. Gojo S, Gojo N, Takeda Y, Mori T, Abe H, Kyo S, Hata J, Umezawa A: In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 288: 51-59, 2003
105. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49, 2002
106. Verfaillie CM, Schwartz R, Reyes M, Jiang Y: Unexpected potential of adult stem cells. Ann NY Acad Sci 996: 231-234, 2003
107. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG: Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89: 1235-1249, 2003
108. Brehm M, Zeus T, Strauer BE: Stem cells - clinical application and perspectives. Herz 27: 611-620, 2002
109. Orlic D: Stem cell repair in ischemic Aeart disease: an experimental model. Int J Hematol, 76(suppl 1): 144-145, 2002
110. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416: 542-545, 2002
111. Vassilopoulos G, Wang PR, Russell DW: Transplanted bone marrow regenerates liver by cell fusion. Nature 422: 901-904, 2003
112. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, Grompe M: Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422: 897-901, 2003
113. Ying QL, Nichols J, Evans EP, Smith AG: Changing potency by spontaneous fusion. Nature 416: 545-548, 2002
114. Hadjantonakis AK, Macmaster S, Nagy A: Embryonic stem cells and mice expressing different GFP variants for multiple non-invasive reporter usage within a single animal. BMC Biotechnol 2: 11, 2002